HMGA2 and cancer: According to the datasets existing in the Oncomine cancer profiling database (www.oncomine.org, accessed on 7 Febuary 2021), HMGA2 is generally more highly expressed in sarcoma, brain and CNS, esophageal, head and neck, lung, melanoma, ovarian, and pancreatic cancers compared to corresponding normal tissue.